Uncovering Key Insights on Nutrien (NTR) Stock

By Emilio Sanchez • Wednesday, September 24 15:17 • Permanent Link

With gains of 4.7%, Nutrien was one of the winners on Wall Street today. Its shares are now trading at $59.04 and have logged a -0.0% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:

Nutrien has moved 19.5% over the last year, and the S&P 500 logged a change of 16.3%
NTR has an average analyst rating of buy and is -11.05% away from its mean target price of $66.38 per share
Its trailing earnings per share (EPS) is $2.78
Nutrien has a trailing 12 month Price to Earnings (P/E) ratio of 21.2 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $3.78 and its forward P/E ratio is 15.6
The company has a Price to Book (P/B) ratio of 1.15 in contrast to the S&P 500's average ratio of 4.74
Nutrien is part of the Industrials sector, which has an average P/E ratio of 24.03 and an average P/B of 2.89
NTR has reported YOY quarterly earnings growth of 221.2% and gross profit margins of 0.3%
The company has a free cash flow of $1.55 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Nutrien Ag Solutions, Potash, Nitrogen, and Phosphate. The Nutrien Ag Solutions segment distributes crop nutrients, crop protection products, seeds, and merchandise products; product application, soil and leaf testing, crop scouting, precision agriculture, water, and brokerage agency services; and financing solutions. The Potash segment provides granular and standard potash products. The Nitrogen segment offers ammonia, urea, environmentally smart nitrogen, nitrogen solutions, nitrates, and sulfates. The Phosphate segment provides solid fertilizer, liquid fertilizer, and industrial and feed products. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.